Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.

2017

This work was supported by “beca SEOM a Jovenes Investigadores 2009” and by the Emili Letang fellowship to Estela Pineda.

Keywords:

References

Citations